Navigation Links
Patient Safety Technologies Announces Expansion of Senior Management Team
Date:1/8/2009

Medical Device Veteran David Bruce Joins as President and Chief Executive Officer

TEMECULA, Calif., Jan. 8 /PRNewswire-FirstCall/ -- Patient Safety Technologies (OTC Bulletin Board: PSTX) today announced that David Bruce has joined the company as its President and Chief Executive Officer and will also join its Board of Directors. Bill Adams, the company's former Chief Executive Officer will remain involved with the company as a consultant.

David brings a breadth of experience successfully managing the growth of medical device businesses. Most recently, David was the Chief Executive Officer of EP MedSystems, Inc., a developer of electrophysiology devices, which was recently acquired by St. Jude Medical. Prior to EP MedSystems, he was the General Manager of the intracardiac echo group of Siemens Medical.

Regarding joining the company, Mr. Bruce stated, "The Safety-Sponge(TM) System addresses a persistent problem that costs U.S. hospitals a conservatively estimated $700 million annually - retained surgical sponges. With key adopters continuing to show outstanding results, this proven system is well positioned to achieve widespread adoption and allow our customers to not only offer a higher standard of patient care but enable them to save money in the process."

About Patient Safety Technologies

Patient Safety Technologies, Inc. (OTC Bulletin Board: PSTX), through its wholly owned subsidiary SurgiCount Medical, Inc., provides the Safety-Sponge(TM) System, a patented FDA 510k approved turn key solution to prevent retained surgical sponges. The system is comprised of surgical sponges and towels affixed with an inseparable two-dimensional data matrix bar code and a SurgiCounter scanner to record each sponge before and after an operation. The SurgiCount Safety-Sponge(TM) System is also the only retained sponge prevention system to offer complete sponge inventory tracki
'/>"/>

SOURCE Patient Safety Technologies
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Fluctuating eye pressure associated with visual field deterioration in glaucoma patients
2. Comparison of obstetric outcomes between on-call and patients own obstetricians
3. Vision restoration therapy shown to improve brain activity in brain injured patients
4. Diabetes appears to increase risk of death for patients with acute coronary syndromes
5. Ambulatory oxygen rarely a benefit in COPD patients without resting hypoxemia
6. Restricting Blood Flow May Help Heart Bypass Patients
7. Patients with Medicaid and those lacking insurance have higher risk of advanced laryngeal cancer
8. Study provides hope that some transplant patients could live free of antirejection drugs
9. Study provides hope that some transplant patients could live free of anti-rejection drugs
10. Longer ambulance journeys boost death risk for seriously ill patients
11. Expenses Overshadow Optimism for Kidney Failure Patients

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/8/2009)...jury of 8 people in the Western District of Pennsy...pain and suffering for a medical malpractice case....ia Nocera of Thomas E. Crenney and Associates, LLC... Monestersky and against the Uniontown Hospital. ... hysterectomy at age 18. , ...
(Date:11/8/2009)...Newswire-USNewswire/ -- Pharmaceutical Research an...sident Ken Johnson released the following statemen..., "We are disappointed, but not surprised by toda...rdworking Americans as well as nearly half of the ...oted against the bill. ,, "While well intention...
(Date:11/8/2009)...ssage of Health Care Reform Bill ,, Critical ...erage for all Americans ,, BALTIMORE, Nov. 7 /...nited States House of Representatives passed criti...ngthen Medicare for seniors and end discrimination...ericans out of affordable health coverage. ,, T...
(Date:11/7/2009)...swire-USNewswire/ -- The American Medical Associat...f Health at the Family Violence Prevention Fund, w...t its semi-annual policy-making meeting. The Cita...r the AMA House of Delegates bestows on a non-phys...i-bin/prnh/20081209/AMALOGO ) ,, "Ms. James h...
(Date:11/7/2009)...holics have a responsibility to vigorously oppose ...uo." ,, WASHINGTON, Nov. 7 /PRNewswire-USNe...rown released the following statement on the news ...ancy Pelosi,s Affordable Health Care for America A...he status quo for abortion is voted upon. ,, "...
Breaking Medicine News(10 mins):Health News:Pennsylvania Jury Awards $2.3 Million to Fayette County Woman in Medical Malpractice Case 2Health News:PhRMA Statement on House Passage of Health Care Reform Bill 2Health News:PhRMA Statement on House Passage of Health Care Reform Bill 3Health News:AARP Maryland Key Vote News Alert 2Health News:AARP Maryland Key Vote News Alert 3Health News:AMA Honors Family Violence Prevention Expert 2Health News:Statement Regarding Cardinal Rigali's Memo Protecting the 'Status Quo' On Life 2
... prescribed to lower cholesterol, may have protect...inic cohort study looked at three different aspect...tile dysfunction and prostate enlargement. Initial...al audio and video resources, including excerpts f...
...that outcomes of robotic assisted kidney cancer su...igh volume centers, prove more beneficial to patie...hored by Fox Chase robotic surgeon Rosalia Viterbo...ve the entire or a portion of the kidney. This is ...
...rts to cut back, , , SATURDAY, April 25 (H... the most important lifestyle changes people with ... the recommendation, a new study has found. , Res...e with heart failure is 2,000 milligrams, particip...
...astic Surgery increased too, with breast implants ..., bigger bank balances and stunning senior celebs ... April 25 A NEW trend in beauty has been seen by ...ving non-surgical treatments including Botox, derm...
...nsurance coverage affect their access to quality c...Cancer Center, insurance coverage may not only aff...e quality of care they receive. Research findings,...scovered a discrepancy in the type of surgical tre...
...tiple doctors who write prescriptions for drugs to...more on the importance of making sure that every d...sten to this report from Prescription Solutions at...xt, graphics and photos for free and unrestricted ...
Other Medicine News:Health News:Major statin study reveals several important findings for reducing prostate cancer and disease 2Health News:Major statin study reveals several important findings for reducing prostate cancer and disease 3Health News:Major statin study reveals several important findings for reducing prostate cancer and disease 4Health News:Robotic assisted kidney cancer surgery proves to be beneficial to patients 2Health News:Hidden Salt in Diet Haunts Many With Heart Failure 2Health News:Growth of Plastic Surgery & Botox Grannies in UK 2Health News:Growth of Plastic Surgery & Botox Grannies in UK 3Health News:Does a person's insurance coverage affect their access to quality cancer care? 2
(Date:11/6/2009)....C., Nov. 6 Chimerix, Inc., a biop...ntiviral therapeutics to address life-threatening ...the company,s lead antiviral compound, CMX001, to ... Health Security Initiative (GHSI). CMX001 is a b...the treatment of smallpox, as well as other seriou...
(Date:11/6/2009)...re-FirstCall/ -- Caraco Pharmaceutical Laboratorie...tromethamine ophthalmic solution, 0.5% following a...ration (FDA) for Sun Pharma,s Abbreviated New Drug...lmic solution on the first day following patent ex...cally equivalent to Acular® Ophthalmic Soluti...
(Date:11/5/2009)...swire/ -- Althea Technologies, Inc., a leading pro...r biopharmaceutical products announced the additio...pany,s platform of services, which will be oversee...tor of Formulation Development. This investment in... scientists, along with new laboratory facilities ...
Breaking Medicine Technology:Chimerix Updates the World Health Organization and the Global Health Security Initiative on Development of CMX001 as a Broad-Spectrum Therapeutic for Smallpox 2Chimerix Updates the World Health Organization and the Global Health Security Initiative on Development of CMX001 as a Broad-Spectrum Therapeutic for Smallpox 3Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Acular(R) Opthalmic Solution 2Althea Technologies Adds Formulation Development to Its Integrated Offering of Contract Services 2RiversEdge BioVentures LLC to Provide Advisory and Investment Services in Life Sciences 13993 1RiversEdge BioVentures LLC to Provide Advisory and Investment Services in Life Sciences 13993 2GENova to acquire three new drug target patents worth in excess of 241 billion in royalty fees 56862 1GENova to acquire three new drug target patents worth in excess of 241 billion in royalty fees 56862 2GENova to acquire three new drug target patents worth in excess of 241 billion in royalty fees 56862 3Amylin Pharmaceuticals and Biocon Limited Enter a Global Development and Commercialization Agreement for a Novel Peptide Hybrid 56858 1Amylin Pharmaceuticals and Biocon Limited Enter a Global Development and Commercialization Agreement for a Novel Peptide Hybrid 56858 2Amylin Pharmaceuticals and Biocon Limited Enter a Global Development and Commercialization Agreement for a Novel Peptide Hybrid 56858 3Amylin Pharmaceuticals and Biocon Limited Enter a Global Development and Commercialization Agreement for a Novel Peptide Hybrid 56858 4
...l Therapeutics (CTI),(Nasdaq and MTA: CTIC) announ...nd Drug Administration (FDA), CTI expects to begin...) and request priority review for pixantrone to tr...L) in the first quarter of 2009.,If granted priori... the end of,2009. , "This communication from t...
...t Angiolix has similar efficacy to Avastin alone a...th potentially less side-effects; study validates ...DALLAS, Jan. 26 ACCESS PHARMACEUTICALS, INC. (OTC...k on its proprietary humanized monoclonal antibody... with high affinity to the its target, lactadherin...
Other Medicine Technology:Pixantrone Pre-NDA Communication from FDA Provides Cell Therapeutics Basis to Begin Rolling NDA Submission 2Pixantrone Pre-NDA Communication from FDA Provides Cell Therapeutics Basis to Begin Rolling NDA Submission 3Access Pharmaceuticals Presents new Combination Data on the Company's Angiolix(R) Therapeutic Monoclonal Antibody 2Access Pharmaceuticals Presents new Combination Data on the Company's Angiolix(R) Therapeutic Monoclonal Antibody 3
...is a national reference laboratory and a worldwide...lopment. ARUP offers an extensive test menu of hig...nd anatomic pathology. Owned by the University of ... half of the nation's university teaching hospital...
...is a national reference laboratory and a worldwide...lopment. ARUP offers an extensive test menu of hig...nd anatomic pathology. Owned by the University of ... half of the nation's university teaching hospital...
...is a national reference laboratory and a worldwide...lopment. ARUP offers an extensive test menu of hig...nd anatomic pathology. Owned by the University of ... half of the nation's university teaching hospital...
...is a national reference laboratory and a worldwide...lopment. ARUP offers an extensive test menu of hig...nd anatomic pathology. Owned by the University of ... half of the nation's university teaching hospital...
Medicine Products: